Answers are grounded in this paper and cite their sources.
An anion-directed assembly strategy has been developed for the construction of nickel(II) Schiff base complexes with diverse coordination architectures. The Schiff base ligand 1-(((2-(pyrrolidin-1-yl)ethyl)imino)methyl)naphthalen-2-ol (HL) was employed for the preparation of four new nickel(II) complexes, namely [Ni 3 (µ 2 -η 1 :η 1 -OAc) 2 (µ 2 -η 2 :η 1 -OAc) 2 L 2 ] ( 1 ), [NiL(NCS)] ( 2 ), [Ni(HL) 2 ](NO 3 ) 2 ( 3 ), and [NiL(N 3 )] ( 4 ). All complexes were characterized by single-crystal X-ray diffraction, revealing that the auxiliary anions play a crucial role in directing the assembly process and determining the final coordination motifs. The antibacterial activities of HL and the complexes were evaluated against Gram-positive and Gram-negative bacterial strains. All nickel complexes exhibit improved antibacterial activity compared with the free ligand, and the trinuclear complex 1 shows the highest overall antibacterial efficiency among the investigated complexes. This work highlights the significant role of auxiliary anions in regulating nickel(II) Schiff base assembly and provides a useful approach for designing coordination compounds with tunable structures and biological properties.
No takes yet. Share an insight, caveat, or question.
You et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: